A high prevalence of multi-drug resistant Gram-negative bacilli in a Nepali tertiary care hospital and associated widespread distribution of Extended-Spectrum Beta-Lactamase (ESBL) and carbapenemase-encoding genes

Background Multi-drug resistance (MDR) and extensive-drug resistance (XDR) associated with extended-spectrum beta-lactamases (ESBLs) and carbapenemases in Gram-negative bacteria are global public health concerns. Data on circulating antimicrobial resistance (AMR) genes in Gram-negative bacteria and their correlation with MDR and ESBL phenotypes from Nepal is scarce. Methods A retrospective study was performed investigating the distribution of ESBL and carbapenemase genes and their potential association with ESBL and MDR phenotypes in E. coli, Klebsiella spp., Enterobacter spp. and Acinetobacter spp. isolated in a major tertiary hospital in Kathmandu, Nepal, between 2012 and 2018. Results During this period, the hospital isolated 719 E. coli, 532 Klebsiella spp., 520 Enterobacter spp. and 382 Acinetobacter spp.; 1955/2153 (90.1%) of isolates were MDR and half (1080/2153) were ESBL producers. Upon PCR amplification, blaTEM (1281/1771; 72%), blaCTXM-1 (930/1771; 53%) and blaCTXM-8 (419/1771; 24%) were the most prevalent ESBL genes in the enteric bacilli. BlaOXA and blaOXA-51 were the most common blaOXA family genes in the enteric bacilli (918/1771; 25%) and Acinetobacter spp. (218/382; 57%) respectively. Sixteen percent (342/2153) of all isolates and 20% (357/1771) of enteric bacilli harboured blaNDM-1 and blaKPC carbapenemase genes respectively. Of enteric bacilli, Enterobacter spp. was the most frequently positive for blaKPC gene (201/337; 60%). The presence of each blaCTX-M and blaOXA were significantly associated with non-susceptibility to third generation cephalosporins (OR 14.7, p < 0.001 and OR 2.3, p < 0.05, respectively).The presence of each blaTEM, blaCTXM and blaOXA family genes were significantly associated with ESBL positivity (OR 2.96, p < 0.001; OR 14.2, p < 0.001 and OR 1.3, p < 0.05 respectively) and being MDR (OR 1.96, p < 0.001; OR 5.9, p < 0.001 and OR 2.3, p < 0.001 respectively). Conclusions This study documents an alarming level of AMR with high prevalence of MDR ESBL- and carbapenemase-positive ESKAPE microorganisms in our clinical setting. These data suggest a scenario where the clinical management of infected patients is increasingly difficult and requires the use of last-resort antimicrobials, which in turn is likely to intensify the magnitude of global AMR crisis.

Background Gram-negative bacilli, particularly those in the bacterial family Enterobacteriaceae (e.g. Klebsiella spp. and Enterobacter spp.) and Acinetobacter spp. are common causes of serious community and hospital-acquired infections. These Gram-negative bacilli are also members of the ESKAPE group of pathogens [1].These are notoriously associated with antimicrobial resistance (AMR) and frequently carry genes that induce resistance to three or more classes of antimicrobials, making them multi-drug resistant. Such multi-drug resistant Gram-negative bacilli represent a significant global public health problem as they are more commonly associated with worse outcomes than susceptible isolates [2][3][4][5].The situation with multi-drug resistant Gram-negative bacilli is particularly alarming in South Asia, which is considered as a global epicentre of these microorganisms [6,7]. Extended-spectrum beta-lactamases (ESBLs) are enzymes that can hydrolyse and therefore inactivate betalactam antimicrobials such as penicillins, cephalosporins and monobactams. ESBL activity is an important mechanism by which Gram-negative bacilli exhibit resistance against beta-lactam antimicrobials. Multiple ESBL variants have been detected and grouped into several structural and evolutionary families which include TEM, SHV, CTX-M, PER, VEB, GES, BES, TLA and OXA [8]. Of these, CTX-M and TEM are the most common ESBLs, while OXA enzymes such as OXA-48, 23, 24, 51, 58 are common carbapenemases that are associated with Gramnegative bacteria that cause nosocomial infections [8,9].
The possession of ESBLs increases the risk of treatment failure with beta-lactam antimicrobials, may contribute to the spread of AMR in Gram-negative bacteria and may complicate infection control in hospital [9,10]. Therefore, detection and reporting for the presence of ESBLs in bacterial pathogens are important for clinical care. This is also essential for developing optimal infection control measures in hospital [10]. Modified disc diffusion tests are routinely used to detect the presence of ESBLs and establish the nature of ESBL phenotypes [11]. Though being useful, these phenotypic detection methods are labour intensive and do not determine the classes of genes that are associated with ESBL activity. Molecular methods like PCR, DNA hybridization, or whole genome sequencing (WGS) may be used alongside phenotypic test methods to detect the presence of ESBL and carbapenemase associated genes and generate additional information regarding the epidemiological distribution of key resistance genes in sentinel locations [10].
South Asia is a key location for antimicrobial resistant pathogens. A high prevalence of MDR and ESBL positive Enterobacteriaceae family bacteria and Acinetobacter have been reported across the region [12][13][14][15][16][17][18][19]. However, little is known about various ESBL and carbapenemase genes associated with these phenotypes in Gram-negative bacilli isolated in hospitals of Nepal. Furthermore, there are little data originating from this region on the association of these genotypes with the observed phenotypes. Such data are important for assessing the contribution of combined phenotypic and genetic tests on clinical care and providing better understanding of the impact of resistance genes on the epidemiology of circulating pathogens.
Here, aiming to better understand the epidemiology of multi-drug resistant microorganisms and improve clinical care in our healthcare facility, we determined the AMR profile of all E. coli, Klebsiella spp., Enterobacter spp. and Acinetobacter spp. isolated from in-and out-patients at a major tertiary hospital in Kathmandu, Nepal, between June 2012 and December 2018. We additionally screened them for the phenotypic presence of ESBL activity by disc diffusion method and performed PCR amplification to detect any ESBL and carbapenemase associated AMR genes. Lastly, we investigated the relationship between the presence of bla CTX-M , bla TEM and bla OXA genes with an ESBL or MDR phenotype. Understanding the association between AMR genotype and phenotype is crucial to assess the value of genetic detection methods in clinical settings.

Study design
This was a retrospective study of anonymised routine microbiology laboratory results originating from Patan Hospital in Lalitpur metropolitan city of the Kathmandu Valley, Nepal. All data regarding E. coli, Klebsiella spp., Enterobacter spp. and Acinetobacter spp. that were isolated from June 2012 to December 2018 were included in this study. These data were devoid of any personal identification information as this work was performed as a component of routine surveillance for infection control at Patan Hospital. management of infected patients is increasingly difficult and requires the use of last-resort antimicrobials, which in turn is likely to intensify the magnitude of global AMR crisis.

Antimicrobial susceptibility testing
Antimicrobial susceptibility testing was performed at the time of bacterial isolation by modified Kirby-Bauer disc diffusion method, as previously described [20]. Zone size interpretations were performed following the appropriate Clinical and Laboratory Standards Institute (CLSI) guidelines [21]. The antimicrobials against which organisms were tested are listed in Additional file 1: Table S1; not all isolates were tested for all antimicrobials. The bacteria producing resistant or intermediate response against tested antimicrobials were grouped as "non-susceptible" for the purposes of analysis. MDR was defined as an acquired non-susceptibility (without intrinsic resistance) to at least one agent of three or more antimicrobial classes. Intrinsic resistance was defined according to the CLSI guideline of 2014 [21]. The following intrinsic resistance were reported but ignored for the purpose of generating MDR profiles: (i) Acinetobacter spp. resistant against amoxicillin or penicillin, (ii) E. coli, Klebsiella, Enterobacter, or Acinetobacter spp. against vancomycin, teicoplanin, erythromycin or azithromycin. Phenotypic testing for ESBL positivity was conducted using the combination disc diffusion method with a betalactam antimicrobial disc alone and that in combination with a beta-lactamase inhibitor (clavulanic acid) [22]. The isolate was considered as ESBL positive if the zone of inhibition around the beta-lactamase inhibitor supplemented disc was ≥ 5 mm in comparison to the respective beta-lactam antimicrobial alone. The products of Mast diagnostics (Mast group Ltd., Liverpool, UK) namely D62C and D68C were used in this study.
For analysis purpose, the detection of any of bla OXA , bla OXA1_4_30 , bla OXA23 , bla OXA24 , bla OXA48 , bla OXA51 or bla OXA58 was designated as bla OXA positive. Similarly, the detection of any of bla CTXM-1 , bla CTXM-2 , bla CTXM-8 , bla CTXM-9 or bla CTXM-25 was designated as bla CTXM positive. Fisher's exact test was used to test for an association between the detection of a resistance gene and a specific resistance phenotype (ESBL positive, MDR, or resistance to third and fourth generation cephalosporins). All analyses were performed using the statistical software R version 3.5.3 and R Studio version 1.0.143. Venn diagrams were generated using the UpSetR R package [28].

The association of ESBL genes with ESBL phenotypes
For all subsequent analysis, isolates were classified as bla OXA or bla CTXM positive if any gene in the bla OXA or bla CTXM gene families were detected respectively. First, we assessed the association between phenotypic ESBL positivity and the presence of bla OXA , bla CTXM, and bla TEM ( Table 4). The detection of each of these genes was significantly associated with an ESBL phenotype. The strength of association was variable between different   n % a n % a n % a n % a n % a n % a n % a Organisms Genes IMP KPC NDM1 SHV TEM VIM n % a n % a n % a n % a n % a n % a Next, the association between ESBL positivity and various combinations of bla OXA , bla CTXM and bla TEM resistance genes were investigated. The isolates that were tested for at least one member of bla OXA family, one member of bla CTXM family and bla TEM were analysed. A distribution of different combinations of bla OXA , bla CTXM and bla TEM resistance genes with ESBL positivity is shown in Fig. 2. The most frequent (485/1955; 24.8%) combination of genes that was associated with ESBL positivity was at least one member of bla OXA family gene, with at least a member of bla CTXM family gene and bla TEM gene. A smaller proportion of isolates (176/1955; 9.0%) was PCR positive for bla OXA , bla CTXM and bla TEM , but was phenotypically ESBL negative. The second most common (242/1955; 12.3%) gene combination associated with ESBL positivity was bla CTXM with bla TEM . The proportion of isolates that were phenotypically ESBL positive, but PCR

The association of ESBL genes with non-susceptibility to third and fourth generation cephalosporins
We also tested for the association between non-susceptibility to third and fourth generation cephalosporins (Cefotaxime, Cefepime, Ceftriaxone and Cefixime) and the presence of bla OXA , bla CTXM, or bla TEM ( Table 4).
The bla CTXM and bla OXA gene families were significantly associated with non-susceptibility to third and fourth generation cephalosporins with odds ratios of 14.7 (95% CI 6.6-38.6, p < 0.001) and 2.03 (95% CI 1.2-3.5, p < 0.05) respectively. The most frequent combination (654/2121; 30.8%) associated with non-susceptibility against third and fourth generation cephalosporins was the presence of all three bla OXA , bla CTXM , and bla TEM genes, followed by the presence of bla CTXM and bla TEM only (357/2121; 16.8%). Only 8.9% (189/2121) of isolates that were phenotypically non-susceptible to third and fourth generation cephalosporins were PCR amplification negative for bla OXA , bla CTXM, and bla TEM (Fig. 3).

The association of ESBL genes with MDR
We similarly investigated for any potential association between the presence of bla OXA , bla CTXM or bla TEM genes with MDR (  (Fig. 4). As MDR was defined as an acquired non-susceptibility to at least one agent in three different classes of antimicrobials, a multi-drug resistant phenotype can originate from a multitude of individual antimicrobial resistant phenotypes. Therefore, we compared the pattern of resistance for the isolates originating from outpatients (emergency ward and outpatient department, Fig. 5a) and that from inpatients (all other wards, Fig. 5b). For the microorganisms originating from the outpatients, the three most frequent AMR combinations accounted for over half (322/535; 60.2%) of all outpatient isolates. For the microorganisms originating from the inpatients, the three most frequent AMR combinations accounted only for 26% of all inpatient isolates (282/1057) and the diversity of resistant phenotypes was much broader than that from outpatient isolates.  Fig. 3 Association between non-susceptibility to 3rd and 4th generation cephalosporins and combinations of resistance genes bla OXA , bla CTXM and bla TEM . Black circles represent non-susceptibility to cephalosporins (3rd/4th gen.) and/or the detection of resistance genes of bla OXA family, bla CTXM family or bla TEM . A grey circle indicates that a characteristic was not detected. The vertical bars indicate the number of isolates in the group summarized directly below. The horizontal bars indicate the total number of isolates positive for resistance genes of bla OXA family, bla CTXM family, for bla TEM or for non-susceptibility to 3rd and 4th generation cephalosporins. An isolate was classified as bla OXA positive if any gene of bla OXA family was detected. The same is true for bla CTXM genes. Only isolates that had a known 3rd and 4th generation cephalosporin resistance profile and were tested for at least one member of bla OXA family, at least one member of bla CTXM family and bla TEM were included Manandhar et al. Ann Clin Microbiol Antimicrob (2020) 19:48

Discussion
In this study, very high prevalence of ESBL positivity and MDR was found in Enterobacteriaceae family bacteria (E. coli, Klebsiella spp. and Enterobacter spp.). Similar MDR prevalence has been reported in other studies from Nepal, but the ESBL positive prevalence we observed (over 50%) is higher than others have reported. For example, one study from Nepal found that in communityacquired infections caused by E. coli, 24% were ESBL positive and 78% had MDR [12]. Another hospital-based study from Nepal showed that in urine samples, 27% of E. coli were ESBL positive and 97% of Enterobacteriaceae bacteria (mostly E. coli and Klebsiella spp.) were multidrug resistant [13]. For Acinetobacter spp., we report over 81% MDR, similar to what others have reported in ICUs in Nepal, but the ESBL prevalence we found (< 1% in Acinetobacter spp.) is much lower than what has been reported (around 12-13%) [15,16,29]. In the context of South Asia, 79% of Acinetobacter spp., 71% of Klebsiella spp. and 54% of E. coli isolated from young infants were estimated to be multi-drug resistant strains [19]. ESBL positivity was confirmed in 42% of K. pneumoniae and 33% of E. coli isolated from several hospitals in India [30], 40% in Enterobacteriaceae isolates from Pakistan [18] and 16% in enteric and non-enteric Gram-negative bacilli from Bangladesh [31].
To limit the spread of antimicrobial resistant microorganisms, to guide clinical care and improve patients'  Fig. 4 Association between MDR and combinations of resistance genes bla OXA , bla CTXM and bla TEM . Black circles represent MDR and/or the detection of resistance genes of bla OXA family, bla CTXM family or bla TEM . A grey circle indicates that a characteristic was not detected. The vertical bars indicate the number of isolates in the group summarized directly below. The horizontal bars indicate the total number of isolates positive for resistance genes of bla OXA family, bla CTXM family, for bla TEM or for MDR phenotype. An isolate was classified as bla OXA positive if any gene of bla OXA family was detected. The same is true for bla CTXM genes. Only isolates that had an AMR profile and were tested for at least one member of bla OXA family, at least one member of bla CTXM family and bla TEM were included outcome, it is essential to have precise knowledge on AMR profile of the infecting bacteria prior to starting antimicrobial therapy to select an appropriate drug. Antimicrobial sensitivity testing and detection of ESBL positivity can be performed by classical phenotypical methods such as disc diffusion, which is labour intensive and time consuming. Automated systems exist, but their installation, running and maintenance costs are often a barrier in low resource settings. Alternatively, simple genetic methods such as PCR can detect AMR genes rapidly and with high sensitivity [2,10,32]. A better understanding of the association between phenotype and genotype is a prerequisite to evaluate the usefulness of genetic detection methods in clinical settings. In this study, we assessed the correlation between the detection of bla CTXM , bla TEM and bla OXA genes by PCR and ESBL positivity or MDR as detected phenotypically by disc diffusion. For E. coli, Enterobacter spp. and Klebsiella spp., the resistance genes most frequently detected were bla OXA , bla TEM , bla CTXM-1 and bla CTXM-8 .This is consistent with a study performed in 2012-2013 at Kathmandu Medical College and Teaching Hospital, in which bla CTXM and bla TEM were frequently detected in ESBL positive E. coli [14]. A study from Bangladesh reported bla CTXM-1 (51%) and bla SHV (27%) to be the most common ESBL genes in Klebsiella pneumoniae [17]. In Pakistan and India, as in our study, bla OXA , bla TEM and bla CTXM , in addition to bla SHV were detected to be common AMR genes in Enterobacteriaceae isolates [18,30]. For Acinetobacter spp., bla OXA-51 , bla OXA-23 and bla NDM-1 were the most frequently detected AMR genes, as found by others in Nepal, India and Bangladesh [33][34][35].
The detection of any gene of the bla CTXM family was strongly associated with ESBL positivity (OR 14.2, 95% CI11.2-18.1), MDR (OR 5.99, 95% CI 4.2-8.6) and resistance to 3rd and 4th generation cephalosporins (OR 14.7, 95% CI 6.6-38.6). The detection of bla TEM was strongly associated with ESBL positivity (OR 2.96, 95% CI 2.5-3.6) and MDR (OR 1.96, 95% CI 1.4-2.7). An association between bla TEM and resistance to 3rd and 4th generation cephalosporins was suggested by an OR of 1.4, but it was not statistically significant (95% CI 0.8-2.4), perhaps due to low number of isolates susceptible to 3rd and 4th generation cephalosporins. Finally, the detection of any gene of the bla OXA family was associated with multi-drug resistant phenotype (OR 2.3, 95% CI 1.7-3.1). This suggests that the detection of bla TEM , or any gene of the bla CTXM or bla OXA family is an important index for multidrug resistant phenotype, and as expected, the detection of a bla CTXM family gene or bla TEM indicates a higher odds of ESBL positive phenotype. Collectively, this suggests that the detection of key AMR genes by molecular methods is an important index for ESBL positivity and MDR in bacterial isolates.
In this study, we also described different AMR patterns found in the isolates originating from emergency and outpatient wards (outpatients) compared to all other wards of the hospital (inpatients), which may reflect different usage of antimicrobials in community compared to the hospital. It can be assumed that isolates originating from outpatients reflect what is circulating in communities. For outpatients, the three most frequent AMR combinations accounted for more than half of all isolates. Perhaps people contracting community-acquired infections predominantly self-medicate, which results in exposure to the limited array of antimicrobials that are freely available in shops and pharmacies. Only infections that are (or have become) resistant to those drugs prompt a visit to the hospital. As a result, infections seen in outpatients have similar resistance profile. In contrast, a higher diversity of AMR combinations found in inpatients may reflect a wider array of antimicrobials available and used at hospitals.

Conclusions
MDR along with possession of ESBL and carbapenemase associated resistance genes among Gram-negative bacilli pose a serious problem in therapeutic management of patients. The compromised infection control and inadequate antimicrobial usage policies coupled with high burden of Gram-negative bacilli possessing transferable antimicrobial resistance genes in resource limited settings set out an ideal scenario for the emergence and dissemination of multi-drug resistant pathogens. In this extensive retrospective study, a high burden of multi-drug resistant clinical Gram-negative bacilli possessing diverse ESBL and carbapenemase resistance bla genes were evidenced. Further, our study signifies that there is a high probability of Gram-negative bacilli to be multi-drug resistant and ESBL positive in case of detection of any of bla TEM , bla CTXM or bla OXA family genes.